Eli Lilly & Co. (LLY)
935.58
-18.94
(-1.98%)
USD |
NYSE |
Apr 02, 16:00
935.57
-0.01
(-0.00%)
Pre-Market: 20:00
Eli Lilly Market Cap : 819.44B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 78.97B |
| Viking Therapeutics, Inc. | 4.244B |
| Apellis Pharmaceuticals, Inc. | 5.168B |
| Arcellx, Inc. | 6.713B |
| Moderna, Inc. | 19.20B |
Market Cap Related Metrics
| PE Ratio | 41.42 |
| PS Ratio | 13.08 |
| PEG Ratio | 0.4287 |
| Price to Book Value | 31.50 |
| Price to Free Cash Flow | 142.91 |
| Price | 935.58 |
| Earnings Yield | 2.41% |
| PEGY Ratio | 0.4257 |
| Operating PE Ratio | 28.70 |
| Normalized PE Ratio | 37.71 |